We are excited to invite you to the Indo US Bridging RARE Summit 2024 to be held on Nov 16-18 in New Delhi, India.
Organized in collaboration with the All India Institute of Medical Sciences, New Delhi, the #BridgingRare Summit 2024 will feature an exciting lineup of prominent speakers from India and the US, workshops, and a Gala dinner and Award Ceremony.
Uniquely positioned to accelerate the engagement of the global rare disease community in Orphan Drug R&D
Highly informative and educational sessions
Great networking opportunities
Special focus on India and emerging markets
The event will take place in HYBRID mode with live streaming of sessions and an excellent online networking platform.
Live and in-person at Indian National Science Academy (INSA), New Delhi
Registrations Details
AIIMS Swimming Pool, New Delhi, India
Join us at the #PITCH4RARE contest at the Indo US Bridging RARE Summit 2024!
Are you addressing unmet needs of patients with rare diseases by developing innovative products, diagnostics, therapies, or digital health solutions? Here is your opportunity to showcase to key stakeholders.
Limited startups will be selected to pitch.
Judging panel of senior international leaders from India, France, and the US.
James A. Levine, MD, PhD, Fondation Ipsen
Priyankana Mukherjee, PhD, IKP Eden
Amrit Ray, MD, MBA, Biopharma Executive, Rare Parent
Pankaj Bhargava, MD, ashibio
Dr. Dayaprasad Kulkarani, AarogyaSeva
Anish Bhatnagar, MD, IndoUSrare & Soleno Therapeutics,
Tshaka Cunningham, PhD, Athari Biosciences,
Anand Kannan, IFIA Bharat
Krishna Subramanian, PhD, Seelos Therapeutics
What does it take to qualify a physician’s clinic or hospital as a clinical trial site?
What qualifications or certifications are needed for a doctor to assume the role of Principal or Sub- or Co-investigator?
Survival guide for sites to survive a GCP audit by regulators such as the FDA or CDSCO
Driving patient-centricity, efficiency, and productivity, in clinical trials
Faculty
Harsha Rajasimha, Ph.D., IndoUSrare and Jeeva Clinical Trials
Dr. Rakesh Lodha, AIIMS, Delhi
Michelle Romero, Consultant to CROs and IRB member
Dr. Mathew T. Thomas, Former USFDA India Office Country Director
Prof. Bangarurajan, JSS College of Pharmacy
Who is a patient advocate?
Goal setting for patient advocates
What has patient advocacy achieved?
Role of patient advocacy in drug development
How to be an effective communicator as a patient or caregiver?
Involving Industry and Academics in Drug Development
Jean Campbell, Professional Patient Advocates in Life Sciences (PPALS)
Dr. Ratna Devi, DakshamA Health
Mohua Chakraborty Choudhury, PhD, MPH, IISc
David Rintell, Ed.D, BridgeBio
Nita Patel, BSN, Ex-Amicus Therapeutics
Nahid Zaman, Astrazeneca India
Dr. B.S. Charan, DGHS
Occupational and physical therapies relevant to rare diseases
Self-care, managing emotions, and guilt
Cristol O’Loughlin, RaregiversTM
Vaishali Pai, Tamahar Trust
Team Premas Life Sciences
Debjani Saha, Premas Life Sciences
Dr. Rahul Ramekar, Premas Life Sciences
Lakshman Teja, Premas Life Sciences
Dr. Vikas Sharma, Premas Life Sciences
Priyanka Singh, Premas Life Sciences
Ratna Dua Puri,MD, DM, SIAMG
Neerja Gupta, MD, DM, AIIMS, Delhi
Co-Chairs
Priyankana Mukherjee, PhD, IKP Eden
James A. Levine, MD PhD, Foundation Ipsen
Chief Guest:
Dr. Chandra Sekhar Pemmasani - Minister of State for Rural Development and Communication
Keynote - Abbey Meyers Khushi Bridging RARE Award Honorees:
Dr. Rahul Purwar, Dr. Hasmukh Jain
Frank Sasinowski, JD, MPH
Felicitation
Dr. Abbey Meyers, Founder, NORD
Patient community voices:
Gautam Dongre, NASCO
Shikha Metharamani PWSA - India
Sunil Ladwa, FOP India
Performances:
Tabla recital - Saksham Mishra
BharataNatyam performance - Mansa Gautam and Raunika Negi
Vocal performances - Chetan Chawla and Ms Ridisha
Summit Chairperson
Harsha Rajasimha, MS, PhD, Indo US Organization for Rare Diseases & Jeeva Clinical Trials
Summit Co-Chair
Madhulika Kabra, MD, All India Institute of Medical Sciences, New Delhi (AIIMS-Delhi)
Success stories from the IRDiRC working groups and what we can learn from other countries
Speaker
David A Pearce, PhD, International Rare Disease Research Consortium (IRDiRC)
Co-Chairs
Madhulika Kabra, MD AIIMS Delhi
Paul Mehta, MD, CDC/ATSDR
Speakers/Panelists:
Dr. Manoj Srinivasa, CHG
Dr. Ravi Hiremagalore, CHG
Dr. Amlin Shukla, ICMR TBC
Nisha Venugopal, PhD, IndoUSrare
Kim Bloemendal, Sanofi
Chair
Vijay Chandru, PhD, FNAe, FASc Strand Life Sciences
Speakers/Panelists
K Thangaraj, PhD, CSIR-CCMB
Seema Kapoor, MD, Maulana Azad Medical College
Inderneel Sahai, MBBS, Massachusetts General Hospital
Reety Arora, PhD, CrisprBits
Shaiket Deb, Strand Life Sciences
Suruchi Aggarwal, PhD, Medgenome
Ganesh Sangle, PhD, Shivanka Research
Vamshi Krishna Thamtham, MD, LalPath Labs
AstraZeneca India Representative
Co-Chairs
Neerja Gupta, MD, DM AIIMS-Delhi
Reena Kartha MS PhD, IndoUSrare and University of Minnesota
Speakers/Panelists
Dr. Ashish Gupta, University of Minnesota
Dr. Jayandharan Rao, IIT Kanpur
Madhusudhan V, LifeArc
Moderator:
COE representative
Speakers/Panelists
Christina Raj, CIRMF
Saurabh Singh, RDIF
Nikhil Jayswal, IBD India
Srijan Mittal, Myositis India
Nadir Aman, CDKL5 South Asia
Moderator:
Anil Raina, MPIB, Biopharma Executive
Speakers/Panelists
Parva Purohit, PhD, Shivanka Research
Pankaj Bhargava, MD ashibio
David Rintell, Ed.D, BridgeBio
Selected startups pitching their solutions to pressing unmet needs of patients with rare diseases
Judges Panel:
James A. Levine, MD, PhD, Fondation Ipsen
Priyankana Mukherjee, PhD, IKP Eden
Amrit Ray, MD, MBA, Biopharma Executive, Rare Parent
Pankaj Bhargava, MD, ashibio
Dr. Dayaprasad Kulkarani, AarogyaSeva
Anish Bhatnagar, MD, IndoUSrare & Soleno Therapeutics
Dr. Krishna Subramanian, Seelos Therapeutics
Anand Kannan, IFIA Bharat
Session Chair
Ratna Puri, MD, DM SGRH
Recent FDA regulatory progress and perspectives on cell and gene therapies
Speaker
Peter Marks, MD, PhD CBER, USFDA
Introduction by Dr. Mathew T. Thomas, Former USFDA India Office Country Director
Massive Global Inequities in Access to Orphan Therapies: Perspectives from a Biopharma Executive and Rare Parent
Speaker
Amrit Ray, M.D., M.B.A., Biopharma Executive, Rare Parent
Co-Chairs
Dr. Mathew Thomas, Former USFDA India
Dr. Geeta Jotwani, ICMR
Speakers/ Panelists
Prof. Bangarurajan, JSS College of Pharmacy
Dr. B S Charan, DGHS
Dr. A Visala, CDSCO
Dr. Krishna Subramanian, Seelos Therapeutics
Co-Chairs
David A Pearce, PhD, IRDiRC
Anil Raina, MPIB, Biopharma Executive
Speakers/Panelists
Ginger Davis, PhD, SCTPN
Harpreet Ram, MBA, GARDAccess
Jenifer Waldrop, MSHRD, Rare Disease Diversity Coalition
Dr. Manisha Badak, National Insurance Corporation
Co-Chairs
Dr. Daya Prasad Kulkarani,AarogyaSeva
Co-Chairs
Dr. Sheffali Gulati, AIIMS, New Delhi
Speakers/Panelists
Jaime Raymond, MPH, CDC/ATSDR
Rama Murali, BharathMD Foundation
Alok Bhattacharya, PhD, WWGM
Archana Panda, CureSMA Foundation
Co-Chairs
Shubha Phadke, MD, DM, SGPGI, Lucknow
Ashish Gupta, MD, MPH, UMN
Speakers/Panelists
Bhavna Dhingra, MD, DNB, AIIMS Bhopal
Sankar V. Hariharan, MD, DM SAT Hospital, Trivadrum
Kuldeep Singh, MD, DM, FAMS, AIIMS Jodhpur
Sanjeeva GN, DCH, DNB, Indira Gandhi Institute of Child Health, Bengaluru
Prajnya Ranganath, MD, DM, NIMS, Hyderabad
Developing a Blueprint for US-India Strategic Cooperation for Rare Diseases Research and Orphan Drugs Development
Leaders:
Harsha K Rajasimha, MS, PhD
Amrit Ray, MD
Pankaj Bhargava, MD
WORKING GROUP 1: NBS, Screening, Diagnosis, Patient Registries, Referral Networks
WORKING GROUP 2: Strategy to Achieve Equitable Representation of Indian Diaspora in CRAACO, Clinical Trials
WORKING GROUP 3: Legislative, Regulatory, Financial Advocacy, the ASK: Indian and US Legislators, CDSCO and FDA. E.g., ASHA program for Cancer Clinical Trials.
WORKING GROUP 4: BioSecure ACT and Inflation Reduction Act of USA and Food/Drugs/Cosmetics Act and NPRD of India - How India can play a greater role in affordable Innovation, R&D, and Manufacturing?
All participants pick a working group to lead or contribute or participate in
WG Leaders:
Dr. Seema Kapoor, MAMC
Dr. Ratna Dua Puri, SGRH
Dr. Ratna Devi, DakshamA Health
Rama Murali, BharatMD Foundation
Anil Raina, MPIB
Dr. Mathew T. Thomas, Former USFDA India Office Country Director.
Parva Purohit, PhD, Shivanka Research
Ganesh Sangle, PhD, Shivanka Research
Madhulika Kabra, MD All India Institute of Medical Sciences, New Delhi (AIIMS-Delhi)
Harsha Rajasimha, MS, PhD Indo US Organization for Rare Diseases & Jeeva Clinical Trials
We invite you to share your knowledge and experience with the global rare disease community.
This is an excellent opportunity for you to showcase your work and expand your collaborative network by interacting with rare disease stakeholders including our eminent speakers and panelists from US and India.
We welcome abstracts across a broad range of themes including:
The Indo US Bridging RARE Summit Souvenir will be distributed to all attendees. It showcases speaker profiles, the meeting agenda and special sessions, Sponsors, leadership messages, photographs, Sponsor and exhibitor information, and much more.
Color Advertising | Rates (In $) | Rates (In ₹) |
---|---|---|
Back Cover | $1,500 | ₹ 75,000 |
Inside Cover | $500 | ₹ 35,000 |
Full Page | $350 | ₹ 20,000 |
Half Page | $250 | ₹ 12,000 |
The souvenir book will be designed to have a final size of 8.5”x 11” which will include a ½” border all around. Please follow the below-listed specifications while submitting your ad.
Files that do not meet these requirements will not be accepted. Quality of printing will depend upon the sharpness of the images used.
LAST DATE FOR SUBMISSIONS: 10 October 2024
Indian National Science Academy ( INSA – New Delhi)
Bahadur Shah Zafar Marg, Mata Sundari Railway Colony, Mandi House, New Delhi, Delhi, 110002
The Ashok
50, Niti Marg, Diplomatic Enclave, Chanakyapuri, New Delhi, Delhi 110021
The organizers have blocked rooms at The Ashok at special rates for conference attendees. This is a recommended hotel - please write to the summit Secretariat at summit@indousrare.org to book your accommodation
Here are our recommendations for hotels nearby the venue. Attendees are requested to contact the hotels directly to book their stay.
Travel scholarships for the Indo US Bridging RARE Summit are now open. Apply early as limited slots are available!!